Ernexa Therapeutics (ERNAW) Asset Writedowns and Impairment (2010 - 2022)
Ernexa Therapeutics (ERNAW) reported Asset Writedowns and Impairment of $28000.0 for Q4 2022, up 1033.33% quarter-over-quarter from -$3000.0 in Q4 2020.
Ernexa Therapeutics (ERNAW) Asset Writedowns and Impairment (2010 - 2022) Analysis & Trends
Ernexa Therapeutics has reported Asset Writedowns and Impairment for 12 years, with the latest figure at $28000.0 in Q4 2022.
- For the quarter ending Q4 2022, Asset Writedowns and Impairment changed N/A year-over-year to $28000.0; the trailing twelve-month figure through Dec 2023 stood at $28000.0 (changed 0.0% YoY), and the FY2025 full-year result was $33000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q4 2022 stood at $28000.0, up from -$3000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $406000.0 in Q4 2019, with the low at -$14000.0 in Q2 2019.
- Historically, Asset Writedowns and Impairment has averaged $64909.1 across 4 years, with a median of $28000.0 in 2022.
- The largest YoY upside for Asset Writedowns and Impairment was 1524.0% in 2019 against a maximum downside of 141.18% in 2019.
- Ernexa Therapeutics' Asset Writedowns and Impairment stood at $25000.0 in 2018, then surged by 1524.0% to $406000.0 in 2019, then tumbled by 100.74% to -$3000.0 in 2020, then surged by 1033.33% to $28000.0 in 2022.
- The last three Asset Writedowns and Impairment figures came in at $28000.0 (Q4 2022), -$3000.0 (Q4 2020), and $138000.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ernexa Therapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Dec 31, 2019 | 406,000.00 |
| Dec 31, 2019 | 406,000.00 |
| Sep 30, 2019 | 51,000.00 |
| Sep 30, 2019 | 51,000.00 |
| Jun 30, 2019 | -14,000.00 |
| Jun 30, 2019 | -14,000.00 |
| Mar 31, 2019 | 30,000.00 |
| Mar 31, 2019 | 30,000.00 |
| Dec 31, 2018 | 25,000.00 |
| Dec 31, 2018 | 25,000.00 |
| Sep 30, 2018 | 17,000.00 |
| Sep 30, 2018 | 17,000.00 |
| Jun 30, 2018 | 34,000.00 |
| Jun 30, 2018 | 34,000.00 |